Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Planet 13 HoldingsPLNH +0.33%31 Equity-to-Asset is 0.30 as of Mar. 2026, which is 56% below its 10-year median of 0.68. GuruFocus rates PLNH with a GF Score™ of 31/100 and a GF Value™ of $0.29 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Planet 13 Holdings ranks worse than 83.6% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Planet 13 Holdings's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $43.73 Mil. Planet 13 Holdings's Total Assets for the quarter that ended in Mar. 2026 was $146.92 Mil.
Therefore, Planet 13 Holdings's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.30.
The historical rank and industry rank for Planet 13 Holdings's Equity-to-Asset or its related term are showing as below:
PLNH'
s Equity-to-Asset Range Over the Past 10 Years
Min: -60 Med: 0.68 Max: 0.87
Current: 0.3
During the past 10 years, the highest Equity to Asset Ratio of Planet 13 Holdings was 0.87. The lowest was -60.00. And the median was 0.68.
PLNH's Equity-to-Asset is ranked worse than 83.6% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 0.61
vs PLNH: 0.30
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Planet 13 Holdings Equity-to-Asset Related Terms
Planet 13 Holdings Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Planet 13 Holdings's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Planet 13 Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Planet 13 Holdings Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Planet 13 Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Planet 13 Holdings's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Planet 13 Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Planet 13 Holdings (PLNH) has a Equity-to-Asset of 0.30 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Planet 13 Holdings and its competitors. This is 56% below median its historical median of 0.68. According to the industry distribution chart, Planet 13 Holdings ranks #841 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 83.6%.
Is Planet 13 Holdings' Equity-to-Asset too high?
Planet 13 Holdings' current Equity-to-Asset of 0.30 is 56% below median its 10-year median of 0.68. The Drug Manufacturers industry median Equity-to-Asset is 0.61. Planet 13 Holdings' value of 0.30 is 50.8% below this industry median. Based on the distribution chart, Planet 13 Holdings ranks #841 out of 1006 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Planet 13 Holdings has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Planet 13 Holdings' Equity-to-Asset compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Planet 13 Holdings ranks #841 out of 1006 companies for Equity-to-Asset. This places Planet 13 Holdings in the lower half of its industry. The industry median Equity-to-Asset is 0.61. Planet 13 Holdings' value of 0.30 is 50.8% below this benchmark. While the company's 10-year median is 0.68 vs. the industry median of 0.61, Planet 13 Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.61, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Planet 13 Holdings's current Equity-to-Asset of 0.30 is 50.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Planet 13 Holdings and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Planet 13 Holdings's current Equity-to-Asset is 0.30, which is 56% below median its own 10-year median of 0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Planet 13 Holdings stock overvalued right now?
Based on GuruFocus' analysis, Planet 13 Holdings (PLNH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.29, compared to a current price of $0.12 — trading 58.1% below its estimated fair value. The current Equity-to-Asset is 0.30, which is 56% below median its 10-year median of 0.68 and 50.8% below the Drug Manufacturers industry median of 0.61. Planet 13 Holdings' overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Planet 13 Holdings (PLNH), the current Equity-to-Asset is 0.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Planet 13 Holdings (PLNH) Overvalued in 2026?
Based on GuruFocus' analysis, Planet 13 Holdings stock appears to be undervalued.
The current stock price of $0.12 is trading 58.1% below its estimated GF Value™ of $0.29.
GuruFocus considers Planet 13 Holdings to be Possible Value Trap.
Key valuation signals for PLNH:
Equity-to-Asset: 0.30 (56% below median its 10-year median of 0.68)
GF Value™: $0.29 vs. price of $0.12 (58.1% below fair value)
Industry Position: 50.8% below the Drug Manufacturers median (#841 of 1006)
No single metric tells the full story. See the PLNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Planet 13 Holdings Inc a vertically integrated cultivator and provider of cannabis and cannabis-infused products in the States of Nevada and California, with retail cannabis operations in Illinois. The company owns and manufactures cannabis products under the following brands: HaHa (gummies and beverages), Dreamland (chocolates), TRENDI (vapes and concentrates), Medizin (flower, vapes, concentrates), Leaf and Vine (vapes).
31GF Score
Get the complete analysis for PLNH
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLNH has been successfully added to your 
